Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients

To estimate protection from <i>cytomegalovirus</i> (CMV) replication after solid organ transplantation, CMV serology has been considered insufficient and thus CMV immunity is increasingly assessed by cellular in vitro methods. We compared two commercially available IFN-γ ELISpot assays (...

Popoln opis

Bibliografske podrobnosti
Main Authors: Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer, Monika Lindemann
Format: Article
Jezik:English
Izdano: MDPI AG 2021-01-01
Serija:Vaccines
Teme:
Online dostop:https://www.mdpi.com/2076-393X/9/2/88